| Members |
acceptabilityId |
| pT2: Tumor more than 8 cm in greatest dimension (bone) |
Preferred (foundation metadata concept) |
| pT2: Tumor more than 8 cm in greatest dimension (bone) (finding) |
Preferred (foundation metadata concept) |
| pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing sarcoma) |
Acceptable (foundation metadata concept) |
| pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) |
Preferred (foundation metadata concept) |
| pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) |
Preferred (foundation metadata concept) |
| pT2: Tumor of lung as per AJCC 6th Edition definition (lung) |
Preferred (foundation metadata concept) |
| pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) |
Acceptable (foundation metadata concept) |
| pT2: Tumor of lung as per American Joint Committee on Cancer 6th Edition definition (lung) (finding) |
Preferred (foundation metadata concept) |
| pT2a |
Preferred (foundation metadata concept) |
| pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) (finding) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
Preferred (foundation metadata concept) |
| pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding) |
Preferred (foundation metadata concept) |
| pT2a - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT2a category |
Preferred (foundation metadata concept) |
| pT2a category (finding) |
Preferred (foundation metadata concept) |
| pT2a1 |
Preferred (foundation metadata concept) |
| pT2a1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT2a2 |
Preferred (foundation metadata concept) |
| pT2a2 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) |
Preferred (foundation metadata concept) |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) |
Preferred (foundation metadata concept) |
| pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades muscularis propria (stomach) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades muscularis propria (stomach) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) |
Preferred (foundation metadata concept) |
| pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing sarcoma) |
Acceptable (foundation metadata concept) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) |
Preferred (foundation metadata concept) |
| pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) (finding) |
Preferred (foundation metadata concept) |
| pT2a: Unilateral, one-half of one lobe or less (prostate) |
Preferred (foundation metadata concept) |
| pT2a: Unilateral, one-half of one lobe or less (prostate) (finding) |
Preferred (foundation metadata concept) |
| pT2b |
Preferred (foundation metadata concept) |
| pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) (finding) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
Preferred (foundation metadata concept) |
| pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding) |
Preferred (foundation metadata concept) |
| pT2b - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT2b category |
Preferred (foundation metadata concept) |
| pT2b category (finding) |
Preferred (foundation metadata concept) |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) |
Preferred (foundation metadata concept) |
| pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) |
Preferred (foundation metadata concept) |
| pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades choroid focally (retinoblastoma) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades choroid focally (retinoblastoma) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades deep muscle (outer half) (urinary bladder) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades deep muscle (outer half) (urinary bladder) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades subserosa (stomach) |
Preferred (foundation metadata concept) |
| pT2b: Tumor invades subserosa (stomach) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing sarcoma) |
Acceptable (foundation metadata concept) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) |
Preferred (foundation metadata concept) |
| pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) (finding) |
Preferred (foundation metadata concept) |
| pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) |
Preferred (foundation metadata concept) |
| pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) (finding) |
Preferred (foundation metadata concept) |
| pT2c |
Preferred (foundation metadata concept) |
| pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
Preferred (foundation metadata concept) |
| pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) |
Preferred (foundation metadata concept) |
| pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) |
Preferred (foundation metadata concept) |
| pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding) |
Preferred (foundation metadata concept) |
| pT2c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT2c category |
Preferred (foundation metadata concept) |
| pT2c category (finding) |
Preferred (foundation metadata concept) |
| pT2c: Bilateral disease (prostate) |
Preferred (foundation metadata concept) |
| pT2c: Bilateral disease (prostate) (finding) |
Preferred (foundation metadata concept) |
| pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
Preferred (foundation metadata concept) |
| pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) |
Preferred (foundation metadata concept) |
| pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) |
Preferred (foundation metadata concept) |
| pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) (finding) |
Preferred (foundation metadata concept) |
| pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
Preferred (foundation metadata concept) |
| pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) |
Preferred (foundation metadata concept) |
| pT2d |
Preferred (foundation metadata concept) |
| pT2d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. |
Preferred (foundation metadata concept) |
| pT3 |
Preferred (foundation metadata concept) |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) |
Preferred (foundation metadata concept) |
| pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding) |
Preferred (foundation metadata concept) |
FHIR